Mobvoi, which claims to be China’s largest revenue-generating artificial intelligence (AI) company focusing on content generation, has filed for a Hong Kong IPO.
Japan remains a private equity hotspot despite muted buyout activity elsewhere in Asia. Take-private and sponsor-to-sponsor opportunities make for a more textured local market
Goldman Sachs has clocked a healthy return from ReNew Energy Global after helping the company diversify its offering and navigate the regulatory pitfalls of India’s renewables space
Careful target selection – based on geography and sector – and increased emphasis on cost controls during ownership will be critical factors for Asian private equity investors as the industry braces for a downturn, according to Bain & Company.
China has sought to facilitate overseas IPOs by local companies through the introduction of a new regulatory regime to guide the process.
Pan-regional GPs get traction by highlighting their Asia ex-China credentials; buyouts rebound as growth capital – and China – continue to recede; India impresses with bumper exit proceeds
Private markets investors have responded to the drop-off in US IPO activity by exploring listings within Asia, while M&A is expected to play a more important role, the AVCJ Private Equity & Venture Forum heard.
Indian drug maker Mankind Pharma has filed for a domestic IPO, setting up an exit for Capital International, a private equity arm of Capital Group.
Nominations for the 2022 AVCJ Private Equity & Venture Capital Awards have now closed. Many thanks to all those who participated.
Navis Capital Partners has sold 100% of B Medical Systems, a Luxembourg-based biotech cold chain provider with significant Asian operations, at an enterprise value of EUR 460m (USD 469m).
Australia’s Potentia Capital has agreed to exit its position in local mining software provider Micromine to UK-based industrial software player AspenTech in a deal worth AUD 900m (USD 623m).
Private equity firms are increasingly presenting portfolio companies’ sustainability credentials in a prepared and formal way in trade sale situations. It appears to be worth the trouble
Quadrant Private Equity has exited Australian hygiene apparel brand Modibodi to Swedish strategic Essity for AUD 140m (USD 96m).
Indian early-stage investor 8i Ventures has made a partial exit of its seed shares in local banking software supplier M2P Fintech, generating a 36x multiple and an IRR of 415% after two years.
TPG Growth and Temasek Holdings have invested a combined INR 10.5bn (USD 136m) in Indian eyecare chain Dr. Agarwal’s Eye Hospital, setting up an exit for ADV Partners.
Actis has sold Indian renewables platform Sprng Energy, including its flagship solar business Solenergi Power, to Shell Overseas investment for USD 1.55bn.
Gogox, a last-mile logistics company formed through the merger of Hong Kong's GoGoVan and an affiliate of mainland China-based 58.com, has filed to list in Hong Kong
EQT Private Equity Asia has acquired majority stake in Guardian Hygiene Service, China’s largest domestic pest control company, for an undisclosed sum. It facilitates a full exit for Jade Invest.
J-Star has exited dementia-focused nursing care provider Platia to Bain Capital-owned counterpart Nichii Gakkan for an undisclosed sum.
China rebounds as Asia private equity investment ends 2021 with a bang; bright spots in improving fundraising environment; sponsor-to-sponsor exits thrive while PE-backed IPOs stumble
Cheap debt and a desire for assets that deliver technology-driven growth have propelled Asia private equity investment to new highs and supported a resurgence in exits. But fundraising still fails to convince
CLSA Capital Partners (CLSA CP) has sold its remaining shares in Japanese cram school operator BC Ings to Eishinkan, a major player in the segment.
Voting for the 2021 AVCJ Private Equity & Venture Capital Awards has now closed. Many thanks for your participation. The winners will be announced on November 15.
Eneos Holdings, an oil company and active technology investor, has agreed to acquire Japan Renewable Energy (JRE) from Goldman Sachs Asset Management and GIC.